Rahul Shenolikar

732 total citations
47 papers, 531 citations indexed

About

Rahul Shenolikar is a scholar working on Family Practice, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rahul Shenolikar has authored 47 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Family Practice, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Rahul Shenolikar's work include Medication Adherence and Compliance (13 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Rahul Shenolikar is often cited by papers focused on Medication Adherence and Compliance (13 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Rahul Shenolikar collaborates with scholars based in United States, Japan and United Kingdom. Rahul Shenolikar's co-authors include Rajesh Balkrishnan, Fabian Camacho, Roger T. Anderson, J. Timothy Whitmire, Rajesh Balkrishnan, Mark A. Hall, Mark S. Walker, Jacquelyn Hunt, Yelena Rozenfeld and Rafia S. Rasu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Geriatrics Society and Medical Care.

In The Last Decade

Rahul Shenolikar

44 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rahul Shenolikar United States	13	138	125	98	87	85	47	531
Eli J. Korner United States	11	90 0.7×	22 0.2×	108 1.1×	88 1.0×	102 1.2×	20	651
Liza Takiya United States	15	282 2.0×	31 0.2×	86 0.9×	66 0.8×	51 0.6×	47	888
Lonneke Timmers Netherlands	13	303 2.2×	33 0.3×	137 1.4×	80 0.9×	79 0.9×	29	621
R. Kurup Australia	8	197 1.4×	24 0.2×	22 0.2×	310 3.6×	25 0.3×	14	805
Ramsankar Basak United States	13	41 0.3×	31 0.2×	98 1.0×	72 0.8×	163 1.9×	52	700
Pang-Hsiang Liu United States	8	19 0.1×	37 0.3×	48 0.5×	81 0.9×	145 1.7×	13	378
Jason Cooper United Kingdom	14	31 0.2×	21 0.2×	26 0.3×	71 0.8×	44 0.5×	36	724
Megan Moncur United States	8	32 0.2×	29 0.2×	201 2.1×	141 1.6×	220 2.6×	12	793
Karen Worley United States	11	29 0.2×	34 0.3×	83 0.8×	67 0.8×	85 1.0×	21	351

Countries citing papers authored by Rahul Shenolikar

Since Specialization

Citations

This map shows the geographic impact of Rahul Shenolikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Shenolikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Shenolikar more than expected).

Fields of papers citing papers by Rahul Shenolikar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Shenolikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Shenolikar. The network helps show where Rahul Shenolikar may publish in the future.

Co-authorship network of co-authors of Rahul Shenolikar

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Shenolikar. A scholar is included among the top collaborators of Rahul Shenolikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Shenolikar. Rahul Shenolikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Flood, Emuella, et al.. (2025). Patient-Centered Real-World Evidence Framework for Oncology Product Development. Cancer Investigation. 43(10). 934–944.

Shenolikar, Rahul, et al.. (2023). Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting. Cancer Medicine. 12(12). 13415–13425. 3 indexed citations

Cai, Ling, et al.. (2022). Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 40(28_suppl). 402–402. 1 indexed citations

Hung, Anna, Kyung Min Lee, Patrick R. Alba, et al.. (2021). EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer. Cancer Treatment and Research Communications. 27. 100327–100327. 2 indexed citations

Johnson, Courtney, et al.. (2020). Medical oncology referral and systemic therapy of patients with advanced stage urothelial carcinoma. Journal of Comparative Effectiveness Research. 9(13). 945–957. 1 indexed citations

Mehra, Ranee, Huan Huang, Brian Seal, et al.. (2020). Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy. Head & Neck. 42(8). 2030–2038. 2 indexed citations

Olufade, Temitope, Maral DerSarkissian, Rahul Shenolikar, et al.. (2020). Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study. Hereditary Cancer in Clinical Practice. 18(1). 13–13. 3 indexed citations

Dinan, Michaela A., Yanhong Li, Tian Zhang, et al.. (2020). Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012. Journal of Geriatric Oncology. 12(2). 298–304. 5 indexed citations

Johnson, Courtney, et al.. (2020). The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis. 6(4). 17 indexed citations

10.

Johnson, Courtney, et al.. (2020). The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.. PubMed. 6(4). 51–60. 9 indexed citations

11.

Houts, Arthur C., et al.. (2019). Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings. Cancer Treatment and Research Communications. 19. 100121–100121. 17 indexed citations

12.

Subramaniam, Deepa S., Melissa Pavilack, Hairong Huo, et al.. (2019). P2.16-37 Impact of Brain Metastases on Healthcare Utilisation and Costs in Patients with NSCLC Treated with EGFR-TKIs. Journal of Thoracic Oncology. 14(10). S880–S880.

13.

Fisher, Maxine D., Rahul Shenolikar, Paul J. Miller, Moon J. Fenton, & Mark S. Walker. (2018). Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015. Clinical Genitourinary Cancer. 16(6). e1171–e1179. 22 indexed citations

14.

Buck, Philip O., David M. Smith, Rahul Shenolikar, & Debra E. Irwin. (2017). A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children. The Pediatric Infectious Disease Journal. 36(12). 1129–1140. 5 indexed citations

15.

Shenolikar, Rahul, Maxine D. Fisher, Paul J. Miller, Mark S. Walker, & Moon J. Fenton. (2017). Health resource utilization and costs for stage IV bladder cancer in community oncology settings.. Journal of Clinical Oncology. 35(15_suppl). e16032–e16032. 1 indexed citations

16.

Shenolikar, Rahul, et al.. (2011). Costs of asthma among US working adults.. PubMed. 17(6). 409–16. 15 indexed citations

17.

Burch, Steven, et al.. (2009). Employee Health and Frequency of Workers' Compensation and Disability Claims. Journal of Occupational and Environmental Medicine. 51(9). 1041–1048. 10 indexed citations

18.

Balkrishnan, Rajesh, Bhakti Arondekar, Fabian Camacho, et al.. (2007). Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus. Clinical Therapeutics. 29(6). 1306–1315. 11 indexed citations

19.

Shenolikar, Rahul, Rajesh Balkrishnan, Fabian Camacho, J. Timothy Whitmire, & Roger T. Anderson. (2006). Race and medication adherence in Medicaid enrollees with type-2 diabetes.. PubMed. 98(7). 1071–7. 92 indexed citations

20.

Balkrishnan, Rajesh, Rukmini Rajagopalan, Rahul Shenolikar, Fabian Camacho, & Roger T. Anderson. (2006). Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis. Current Medical Research and Opinion. 22(3). 551–559. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact